Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06424626	A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma	enrolling by invitation	Phase 1	60	Peking University Cancer Hospital & InstituteOTHER	1	Jul 13, 2026	clinicaltrials
NCT05893654	Melphalan Chemoreduction for Ocular Melanoma(MELCOM)	enrolling by invitation	Phase 1 / Phase 2	10	Hospital das Clínicas de Ribeirão PretoOTHER	1	Sep 15, 2025